NCT00614601View on ClinicalTrials.gov

Low Dose Vaccine Study for Surgically Resected Pancreatic Cancer

PHASE2TerminatedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

May 31, 2010

Study Completion Date

December 31, 2014

Conditions
Pancreatic Cancer
Interventions
BIOLOGICAL

HyperAcute(R)-Pancreatic Cancer Vaccine

100 million vaccine cells will be injected intradermally for up to 14 vaccinations over approximately 8 months

Trial Locations (1)

40292

University of Louisville, Louisville

Sponsors
All Listed Sponsors
lead

NewLink Genetics Corporation

INDUSTRY

NCT00614601 - Low Dose Vaccine Study for Surgically Resected Pancreatic Cancer | Biotech Hunter | Biotech Hunter